Praluent
Payments companies reported to CMS as associated with Praluent. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Praluent, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Praluent
These are the largest totals companies reported as associated with Praluent. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Rosenson | New York, NY | Cardiovascular Disease | $2,197.72 |
| Dylan Steen | Cincinnati, OH | Cardiovascular Disease | $1,802.50 |
| Deepak Bhatt | New York, NY | Interventional Cardiology | $1,500.00 |
| Stephen Daniels | Aurora, CO | Pediatric Cardiology | $540.00 |
| Paolo Venegoni | Austin, TX | Interventional Cardiology | $458.98 |
| Columbus Batiste | Riverside, CA | Cardiovascular Disease | $448.88 |
| Neva Schmelzer | Austin, TX | Family | $383.34 |
| Robert Wozniak | Austin, TX | Interventional Cardiology | $369.98 |
| Michael Wilkinson | San Diego, CA | Cardiovascular Disease | $331.78 |
| Gregory Lang | Bend, OR | Physician Assistant | $244.78 |
Prescribed Praluent?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.